Concepedia

Author

Katsuyuki Kunieda

Gifu University

Also Known As

K KUNIEDA, K Kunieda, K. Kunieda, Katsuyuki KUNIEDA, Katsuyuki Kunieda, Narutoshi Nagao

150

Publications

953

Citations

15

H-Index

36

Concepts

All Affiliations

Gifu UniversityGifu Prefectural General Medical CenterYokohama City UniversityTokai Central HospitalKyoto University
KK

About

Katsuyuki Kunieda is an author at Gifu University specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

229

2

Health Sciences

4

4

65

3

Cell Biology

3

3

82

4

Anatomy

1

1

17

5

Gastroenterology

1

1

15

Katsuyuki Kunieda

×

20

Publications

761

Citations

15

H-Index

YearCitations

Polo‐like kinase 1 (PLK1) is overexpressed in primary colorectal cancers

Takao Takahashi, Bun Sano, T Nagata,

Cancer Science

2003

267

Fatal erythroderma (suspected graft‐versus‐host disease) after cholecystectomy. Retrospective analysis

Setsuko Otsuka, Katsuyuki Kunieda, Mitsuhiko Hirose,

Transfusion

1989

62

FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study

Shigeyoshi Iwamoto, Tsuyoshi Takahashi, Hiroshi Tamagawa,

Annals of Oncology

2015

62

Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.

Takashi Sakakibara, Fang-An Chen, Hisashi Kida,

PubMed

1996

58

Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902)

Hidetoshi Katsuno, K. Maeda, Takashi Kaiho,

Japanese Journal of Clinical Oncology

2015

41

Large Solitary Fibrous Tumor of the Retroperitoneum: Report of a Case

Katsuyuki Kunieda, Yoshihiro Tanaka, Narutoshi Nagao,

Surgery Today

2004

35

Evaluation of Treatment for Synchronous Hepatic Metastases from Gastric Cancer with Special Reference to Long-Term Survivors

Katsuyuki Kunieda, Shigetoyo Saji, Yasuyuki Sugiyama,

Surgery Today

2002

26

Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study

Naohiro Tomita, Katsuyuki Kunieda, Atsuyuki Maeda,

British Journal of Cancer

2019

26

Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: Covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system

Shigetoyo Saji, Junichi Sakamoto, Satoshi Teramukai,

Surgery Today

1999

23

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study

Takao Takahashi, Yoshihisa Shibata, Yuichiro Tojima,

International Journal of Clinical Oncology

2012

20

Page 1